Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04805424
Other study ID # 2020-06151
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date January 2023
Est. completion date June 2025

Study information

Verified date March 2023
Source Karolinska University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Excess skin on the abdomen is a common problem for many individuals after massive weight loss. The surgical procedure of abdominoplasty is intended to remove excess skin and improve the shape of the torso in abdomen, in order to address issues such as skin fold eczema, difficulties finding clothing, and psychosocial issues. The investigators will conduct a randomized, controlled trial where individuals with excess skin on the abdomen will be randomized to either standard abdominoplasty or abdominoplasty in combination with liposuction. The investigators will examine the rate of complications, and the functional and aesthetical outcomes of the two methods.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility This study is open only to individuals who are residents in Sweden and qualify for government-funded, inpatient, non-emergency health care within the Stockholm Region. Inclusion Criteria: - BMI < 30 - Stable BMI for >= 6 months - >= 24 months since bariatric surgery, if applicable - Skin fold of >= 5 cm - Functional and/or psychosocial issues due to abdominal skin excess Exclusion Criteria: - Smoking - Ongoing infection

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Lipo-abdominoplasty
Abdominoplasty plus liposuction
Abdominoplasty
Abdominoplasty

Locations

Country Name City State
Sweden Reconstructive Plastic Surgery, Karolinska University Hospital Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska University Hospital

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of and type of complications within 30 days Number of and type of complications occurring within 30 days of surgery 30 days
Secondary Average need for analgesia in morphine equivalents Average need for analgesia in morphine equivalents during post-operative day 1 Post-operative day 1
Secondary Average score on BodyQ score Average score on BodyQ score including subscales. BodyQ is developed and owned by Memorial Sloan Kettering Cancer Center. The BODY-Q is composed of 27 independently functioning scales that measure 3 overarching constructs Appearance, Quality of Life and Experience of Care. Scales are translated to a 0-100 score where a lower score means worse outcome. At baseline, at 3 months post-operatively, at 12 months post-operatively
Secondary Average score on aesthetic result Average score on aesthetic result on a 1-10 scale where a lower score means worse outcome. At 12 months post-operatively
Secondary Average days until discharge Average days until discharge post-operatively Days